SD-231831

N/A

Report date: 2026/03/19 17:15:21

Base Information

Drug NameSD-231831

Drug Alias NameSD-231831

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-Trop-2Anti-CD3

TargetsTumor-associated calcium signal transducer 2T cell surface glycoprotein CD3

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesIbio Inc

China Registration ClassN/A

Develop Information

Active CompaniesIbio Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A